Samsung Biologics207940
Samsung Biologics (207940) New Share Issue Price, Nov 5, 2026
Filing date ·
Samsung Biologics said in a November 5, 2026 filing that the final issue price for the new shares in its rights offering is KRW 1.174 million per common share.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.